<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002072'>Chorea</z:hpo> is a <z:hpo ids='HP_0100022'>movement disorder</z:hpo> which may be associated with <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immunologic diseases</z:e>, in particular in the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0002072'>Choreic movements</z:hpo> have been linked to the isolated presence of plasmatic aPL, or to primary, or <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The highest incidence of aPL-related <z:hpo ids='HP_0002072'>chorea</z:hpo> is detected in children and females </plain></SENT>
<SENT sid="3" pm="."><plain>The presentation of <z:hpo ids='HP_0002072'>chorea</z:hpo> is usually <z:hpo ids='HP_0011011'>subacute</z:hpo> and the course monophasic </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0002072'>Choreic movements</z:hpo> can be focal, unilateral, or generalized </plain></SENT>
<SENT sid="5" pm="."><plain>High plasmatic titers of aPL in a choreic patient can suggest the diagnosis of aPL-related <z:hpo ids='HP_0002072'>chorea</z:hpo>; neuroimaging investigation does not provide much additional diagnostic information </plain></SENT>
<SENT sid="6" pm="."><plain>The most relevant target of aPL is Î²2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I, probably responsible for the thrombotic manifestations of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Etiology of the <z:hpo ids='HP_0100022'>movement disorder</z:hpo> is not well understood but a neurotoxic effect of aPL has been hypothesized, leading to impaired basal ganglia cell function and development of neuroinflammation </plain></SENT>
<SENT sid="8" pm="."><plain>Patients affected by aPL-related <z:hpo ids='HP_0002072'>chorea</z:hpo> have an increased risk of <z:mp ids='MP_0005048'>thrombosis</z:mp> and should receive antiplatelet or <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment </plain></SENT>
</text></document>